Study of CMAB807 Post-change in Manufacturing Site and Prolia in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

128

Participants

Timeline

Start Date

November 2, 2023

Primary Completion Date

June 3, 2024

Study Completion Date

July 5, 2024

Conditions

Healthy Volunteers

Interventions

BIOLOGICAL

Post-change CMAB807

for subcutaneous injection only

BIOLOGICAL

Prolia

for subcutaneous injection only

Trial Locations (1)

The Second Hospital of Anhui Medical University, Hefei

All Listed Sponsors

lead

Taizhou Mabtech Pharmaceutical Co.,Ltd

INDUSTRY

NCT06361355 - Study of CMAB807 Post-change in Manufacturing Site and Prolia in Healthy Volunteers | Biotech Hunter | Biotech Hunter